Quest Diagnostics Incorporated logo
DGXQuest Diagnostics Incorporated

Is the current ratio high or low?

The current ratio of 1.18 is in line with its 5-year average of 1.28, around the middle of its 5-year range (0.92–1.76).

As of Friday, June 26, 2026. 0.29% above its 12-month average of 1.18.

Quick Ratio|Debt to Equity|P/B Ratio|All Metrics
Current Ratio

DGX Current Ratio

1.18

Reported quarterly current ratio; no daily interpolation.

-14.81% 5Y
DGX Current Ratio

DGX Average Current Ratio Chart

DGX Current Ratio

DGX Current vs Average Current Ratio Chart

DGX Current Ratio Metrics

CURRENT RATIO

1.18

CURRENT RATIO AVG TTM

1.18

CURRENT RATIO AVG 3Y

1.15

CURRENT RATIO AVG 5Y

1.28

CURRENT RATIO AVG 10Y

1.28

CURRENT RATIO AVG 15Y

1.25

CURRENT RATIO AVG 20Y

1.25

CURRENT VS TTM AVG

+0.29%

CURRENT VS 3Y AVG

+2.86%

CURRENT VS 5Y AVG

-7.98%

CURRENT VS 10Y AVG

-8.21%

CURRENT VS 15Y AVG

-5.46%

CURRENT VS 20Y AVG

-5.41%

DGX Competitors' Current Ratio

NAMEMARKET CAPCURRENT RATIOTTM3Y5Y
Quest Diagnostics Incorporated (DGX)$22.83B1.181.181.151.28
BioNTech SE (BNTX)vs ›$22.76B7.547.507.966.49
United Therapeutics Corporation (UTHR)vs ›$23.07B6.605.926.536.74
Moderna, Inc. (MRNA)vs ›$23.71B3.293.483.282.72
Labcorp Holdings Inc. (LH)vs ›$21.83B1.421.431.381.52
Incyte Corporation (INCY)vs ›$21.48B3.322.653.153.33
Waters Corporation (WAT)vs ›$24.57B1.731.922.082.07
Mettler-Toledo International Inc. (MTD)vs ›$25.13B1.141.081.101.13
STERIS plc (STE)vs ›$20.52B2.092.022.372.27
Veeva Systems Inc. (VEEV)vs ›$25.68B4.894.704.394.08

Liquidity Analysis

Current Ratio

1.18

Quick Ratio

0.96

Current Ratio Formula & Definition

Current Ratio = Current Assets / Current Liabilities

The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Current Ratio FAQ

What is the current ratio for Quest Diagnostics Incorporated (DGX)?
The current ratio for DGX stock is 1.18.
Is Quest Diagnostics Incorporated's current ratio high or low?
The current ratio of 1.18 is in line with its 5-year average of 1.28, around the middle of its 5-year range (0.92–1.76).
What is the TTM average current ratio for Quest Diagnostics Incorporated (DGX)?
The TTM average current ratio for DGX stock is 1.18.
What is the 3Y average current ratio for Quest Diagnostics Incorporated (DGX)?
The 3Y average current ratio for DGX stock is 1.15.
What is the 5Y average current ratio for Quest Diagnostics Incorporated (DGX)?
The 5Y average current ratio for DGX stock is 1.28.
What is the 10Y average current ratio for Quest Diagnostics Incorporated (DGX)?
The 10Y average current ratio for DGX stock is 1.28.
What is the 15Y average current ratio for Quest Diagnostics Incorporated (DGX)?
The 15Y average current ratio for DGX stock is 1.25.
What is the 20Y average current ratio for Quest Diagnostics Incorporated (DGX)?
The 20Y average current ratio for DGX stock is 1.25.

DGX Current Ratio History

DATECURRENT RATIO
2026-03-311.18
2025-12-311.04
2025-09-301.13
2025-06-301.09
2025-03-311.44
2024-12-311.10
2024-09-301.25
2024-06-301.00
2024-03-310.97
2023-12-311.31
2023-09-301.12
2023-06-300.92
2023-03-311.34
2022-12-311.22
2022-09-301.46
2022-06-301.54
2022-03-311.46
2021-12-311.56
2021-09-301.62
2021-06-301.38
2021-03-311.76
2020-12-311.72
2020-09-301.40
2020-06-301.29
2020-03-311.38
2019-12-311.25
2019-09-300.88
2019-06-300.82
2019-03-310.78
2018-12-310.94
2018-09-301.15
2018-06-301.12
2018-03-311.23
2017-12-311.24
2017-09-301.47
2017-06-301.64
2017-03-311.58
2016-12-311.56
2016-09-301.57
2016-06-301.36
2016-03-311.37
2015-12-311.28
2015-09-301.45
2015-06-301.23
2015-03-311.14
2014-12-310.94
2014-09-301.31
2014-06-301.20
2014-03-311.25
2013-12-311.22
2013-09-301.15
2013-06-301.14
2013-03-311.21
2012-12-311.49
2012-09-301.38
2012-06-301.12
2012-03-311.00
2011-12-310.90
2011-09-300.79
2011-06-300.74
2011-03-311.48
2010-12-311.32
2010-09-301.35
2010-06-301.64
2010-03-311.53
2009-12-311.59
2009-09-301.48
2009-06-301.31
2009-03-311.17
2008-12-311.22
2008-09-301.25
2008-06-301.25
2008-03-311.23
2007-12-311.07
2007-09-301.20
2007-06-301.22
2007-03-310.80
2006-12-311.03
2006-09-301.05
2006-06-301.10
2006-03-311.06
2005-12-310.97
2005-09-300.97
2005-06-301.22
2005-03-311.11
2004-12-310.89
2004-09-301.43
2004-06-301.36
2004-03-311.62
2003-12-311.38
2003-09-301.44
2003-06-301.43
2003-03-311.35
2002-12-311.30
2002-09-301.08
2002-06-300.99

Related Metrics

Quick RatioDebt to EquityP/B RatioAll Metrics

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

Secaucus, NJ
55,000 employees
www.questdiagnostics.com
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
James E. Davis
View full financials